Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Clinical trial NCT04602533 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04602533
- Sponsor
- Michael Hopp
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2026-12-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.